Not investment advice.Read full disclaimer
Ipca Laboratories Limited (IPCALAB.BO) annual revenue, net income, and EPS from the income statement, balance sheet, and cash flow statement (2022–2026). Full statements with 20+ years of history are available below.
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | 96.46B | 11.41B | $44.98 |
| 2025 | 89.41B | 7.38B | $29.08 |
| 2024 | 77.06B | 5.47B | $21.57 |
| 2023 | 62.48B | 4.71B | $18.58 |
| 2022 | 58.30B | 8.84B | $34.85 |
Continue with finqOS
Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield